Loading
CERNER Corp Stock: price and insider trades · United States
CERNER Corp: what insiders have been doing
CERNER Corp, founded in 1979, is a Healthcare & Pharma company based in North Kansas City, United States. Its directors and officers file their transactions with SEC (Form 4). The past year has been quiet: not a single insider filing for CERNER Corp. The previous disclosure was published on 9 June 2022.
Our records for CERNER Corp go back to 2021, with no purchases and 3 sales on the open market in total.
Other companies in the same sector with recent insider buying flagged by our signals: Cooper Companies, Inc. and Anixa Biosciences Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
54
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€2M
3 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2021FY ended December 2021 · cache
Income statement
RevenueUS$5B
Net incomeUS$478.4M9.6% margin
Last declaration on 9 June 2022
Declarations54 total
6,246 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035508:0
371 shares@ US$95.008.2% of flowCommon StockSEC:0001209191-22-035484:0
23,438 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035499:0
12,825 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035503:0
26,588 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035504:0
21,909 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035500:0
2,768 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035498:0
844 shares@ US$95.005.3% of flowCommon StockSEC:0001209191-22-035502:0
539 shares@ US$95.0015.5% of flowCommon StockSEC:0001209191-22-035488:0
37,460 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035491:0
43,905 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035493:0
295 shares@ US$95.002.2% of flowCommon StockSEC:0001209191-22-035492:0
15,032 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035497:0
14,525 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035501:0
31,319 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035495:0
2,000 shares@ US$55.7426.1% of flowCommon StockSEC:0001209191-22-027636:0
1,729 shares0Common StockSEC:0001209191-22-026575:0
7,769 shares@ US$93.4046.9% of flowCommon StockSEC:0001209191-22-018181:0
15,000 shares@ US$67.2477.7% of flowCommon StockSEC:0001209191-22-017043:0
7,374 shares0Common StockSEC:0001209191-21-071600:0
4,509 shares0Common StockSEC:0001209191-21-070948:0
4,509 shares0Common StockSEC:0001209191-21-070941:0
4,407 shares0Common StockSEC:0001209191-21-070953:0
11,480 shares0Common StockSEC:0001209191-21-070954:0
5,549 shares0Common StockSEC:0001209191-21-070956:0
25 of 54 declarations
About CERNER Corp
Recent developments are dominated by post-acquisition integration rather than standalone corporate actions. Oracle has been repositioning the Cerner asset base under the Oracle Health banner, with a focus on cloud modernization, AI-enabled clinical tools, and tighter integration with Oracle’s broader data and application stack. In practical terms, that means Cerner’s former strategic themes—EHR modernization, workflow automation, interoperability, and hospital digitization—now sit inside Oracle’s healthcare strategy rather than a separate public company. As a result, SEC Form 4 insider-trading activity is associated with Oracle, not Cerner as an independent issuer. For French, Belgian, and Swiss investors, Cerner is best viewed as a historically important U.S. healthcare software franchise that has been folded into a much larger NASDAQ-listed parent, rather than as a separately traded stock.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
